AVITA Medical to Present at TD Cowen 44th Annual Health Care Conference
VALENCIA, Calif., Feb. 29, 2024 (GLOBE NEWSWIRE) — AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company […]
LPL Financial Welcomes Endeavor Wealth Strategies
SAN DIEGO, Feb. 29, 2024 (GLOBE NEWSWIRE) — LPL Financial LLC announced today that financial advisor Seth Marshall and the […]
EnWave Declares Significant Sales Wins for Royalty-Partner BranchOut Food
VANCOUVER, British Columbia, Feb. 29, 2024 (GLOBE NEWSWIRE) — EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the “Company”) today announced […]
Silynxcom Unveils Groundbreaking Headset for Military Dogs, Offering Unparalleled Protection and Communication
Netanya, Israel, Feb. 29, 2024 (GLOBE NEWSWIRE) — Silynxcom Ltd. (NYSE American: SYNX) (“Silynxcom” or the “Company”), a manufacturer and […]
ANGRY ORCHARD IS HELPING SPRING BREAKERS TRAVEL LIGHT TO CELEBRATE THE LAUNCH OF NEW LIGHT HARD CIDER
WALDEN, N.Y., Feb. 29, 2024 (GLOBE NEWSWIRE) — BYOB is a surefire way to save time and money while spring […]
Check Point Software Technologies Ranked as a Leading Email Security Provider in Latest Industry Analyst Report
SAN CARLOS, Calif., Feb. 29, 2024 (GLOBE NEWSWIRE) — Check Point Software Technologies Ltd. (NASDAQ: CHKP), a leading AI-powered, cloud-delivered […]
DatChat Unleashes AI Dog Racing and Full Monetization in Habytat Metaverse Expansion
Company’s social media ecosystem grows with new update to HabyPets AI-powered game New Brunswick, NJ, Feb. 29, 2024 (GLOBE NEWSWIRE) […]
Rail Vision Joins NVIDIA Metropolis to Boost Railway Safety Systems
Rail Vision uses the NVIDIA Jetson and other NVIDIA edge AI platforms in its advanced railway safety systems Ra’anana, Israel, […]
AIM ImmunoTech Outlines Recent Progress Across Clinical Development Pipeline and Provides Business Update
Company continues progress across Ampligen® clinical development programs Growing body of promising data demonstrates Ampligen’s potential to address multiple high-value […]
SciSparc Delivers Treatment for Autism Spectrum Disorder Clinical Trial Enabling Commencement of Dosing
The SCI- 210 treatment is now available at clinical site for autism spectrum disorder clinical trial in pediatric patients, in […]
